ATOS - Atossa Therapeutics, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.06-0.07-0.25-0.25
Low estimate-0.06-0.07-0.25-0.25
High estimate-0.06-0.07-0.25-0.25
Year ago EPS-0.05-0.06-0.21-0.25
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.06-0.06-0.06-0.06
Actual EPS-0.05-0.06-0.06-0.05
Difference0.01000.01
Surprise %16.70%0.00%0.00%16.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.06-0.07-0.25-0.25
7 days ago-0.06-0.07-0.25-0.25
30 days ago-0.06-0.06-0.25-0.25
60 days ago-0.06-0.06-0.25-0.25
90 days ago-0.06-0.06-0.22-0.17
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesATOSIndustrySector(s)S&P 500
Current qtr.-20.00%N/AN/AN/A
Next qtr.-16.70%N/AN/AN/A
Current year-19.00%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A